EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Cytosolic calcium: Judge, jury and executioner of neurodegeneration in Alzheimer's disease and beyond

Elise K Webber, Marc Fivaz, Grace E Stutzmann, Gerard Griffioen

Alzheimer's & Dementia · 2023-08 · 19 (8) · 3701-3717

DOI: 10.1002/alz.13065 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Alzheimer's & Dementia, online erschienen am 03.05.2023. Verfasst von Elise K Webber und 3 weiteren Autor:innen. Beteiligte Einrichtung: Center for Neurodegenerative Disease and Therapeutics, Rosalind Franklin University of Medicine and Science, North Chicago, Illinois, USA. Hauptthemen laut MEDLINE: Alzheimer Disease, Calcium, Cytosol. Die Arbeit wurde bisher 50-mal zitiert (Crossref) und nennt 161 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIA NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This review discusses the driving principles that may underlie neurodegeneration in dementia, represented most dominantly by Alzheimer's disease (AD). While a myriad of different disease risk factors contribute to AD, these ultimately converge to a common disease outcome. Based on decades of research, a picture emerges where upstream risk factors combine in a feedforward pathophysiological cycle, culminating in a rise of cytosolic calcium concentration ([Ca 2+ ] c ) that triggers neurodegeneration. In this framework, positive AD risk factors entail conditions, characteristics, or lifestyles that initiate or accelerate self‐reinforcing cycles of pathophysiology, whereas negative risk factors or therapeutic interventions, particularly those mitigating elevated [Ca 2+ ] c , oppose these effects and therefore have neuroprotective potential.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseCalciumCytosolAnimalsHumansAmyloid beta-PeptidesProteostasisRisk Factorstau Proteins

Stichwörter der Autor:innen

Alzheimer's diseasecalcineurincalciumdementianeurodegenerationsynaptic function

Substanzen

Amyloid beta-PeptidesCalciumtau Proteins

Autor:innen und Institutionen

  • Center for Neurodegenerative Disease and Therapeutics, Rosalind Franklin University of Medicine and Science, North Chicago, Illinois, USA.
  • School of Graduate and Postdoctoral Studies, Rosalind Franklin University of Medicine and Science, North Chicago, Illinois, USA.
  • Drug Discovery and Development Unit, reMYND N.V., Leuven, Belgium.

Förderung

  • NIA NIH HHS

Zitieren

APA

Webber, E. K., Fivaz, M., Stutzmann, G. E., & Griffioen, G. (2023). Cytosolic calcium: Judge, jury and executioner of neurodegeneration in Alzheimer's disease and beyond. Alzheimer's & Dementia, 19(8), 3701-3717. https://doi.org/10.1002/alz.13065

Vancouver

Webber EK, Fivaz M, Stutzmann GE, Griffioen G. Cytosolic calcium: Judge, jury and executioner of neurodegeneration in Alzheimer's disease and beyond. Alzheimer's & Dementia. 2023;19(8):3701-3717. doi:10.1002/alz.13065

BibTeX
@article{Webber2023,
  author = {Webber, Elise K and Fivaz, Marc and Stutzmann, Grace E and Griffioen, Gerard},
  title = {Cytosolic calcium: Judge, jury and executioner of neurodegeneration in Alzheimer's disease and beyond},
  journal = {Alzheimer's & Dementia},
  year = {2023},
  volume = {19},
  number = {8},
  pages = {3701--3717},
  doi = {10.1002/alz.13065}
}
Kostenlos starten →